Cargando…
OR2804 Endocrine And Vision Outcomes Following (90)Yttrium Therapy For Cystic Sellar Lesions—A Prospective Cohort Study
Disclosure: M.A. MacLean: None. S. Ahmad: None. A.L. Hebb: None. A. Tahir: None. R. Greene: None. D.B. Clarke: None. S.A. Imran: None. Background: Untreated cystic sellar lesions can cause vision loss, endocrine dysfunction, and obstructive hydrocephalus related to growth and mass effect. Microsurgi...
Autores principales: | MacLean, Mark A, Ahmad, Syed, Hebb, Andrea L O, Tahir, Anas, Greene, Ryan, Clarke, David B, Imran, Syed Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554141/ http://dx.doi.org/10.1210/jendso/bvad114.1366 |
Ejemplares similares
-
MON-LB076 Patterns of Secondary Hormonal Deficiency Vary among Different Types of Sellar Masses Despite Similar Tumour Size at Presentation
por: Almistehi, Wael, et al.
Publicado: (2019) -
MON-419 Sellar Plasmacytoma: A Commonly Misdiagnosed Sellar Mass
por: Duan, Daisy, et al.
Publicado: (2019) -
ODP294 An Unusual Case of Endocrine Disruption as an Early Expression of Low Grade Intra Sellar Chordoma
por: Babu, Vedesh Kumar, et al.
Publicado: (2022) -
SAT-LB082 Neurosarcoidosis Presenting as Panhypopituitarism, Diabetes Insipidus and Sellar Mass
por: Saini, Khushpreet Kaur, et al.
Publicado: (2019) -
SUN-432 A Case of Sellar Plasmacytoma Masquerading as Pituitary Carcinoma with Hypopituitarism
por: Lee, Christine, et al.
Publicado: (2019)